BioCentury
ARTICLE | Clinical News

Grazax grass pollen Allergy Immunotherapy Tablet regulatory update

April 1, 2013 7:00 AM UTC

ALK-Abello and partner Merck said FDA accepted for review a BLA from Merck for grass pollen AIT. Merck said it expects a decision on the application in 1Q14; the specific PDUFA date is not disclosed. ...